These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 33357065)

  • 1. Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment.
    Zhao Z; Liu W
    Technol Cancer Res Treat; 2020; 19():1533033820962117. PubMed ID: 33357065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the microbiome in occurrence, development and treatment of pancreatic cancer.
    Wang Y; Yang G; You L; Yang J; Feng M; Qiu J; Zhao F; Liu Y; Cao Z; Zheng L; Zhang T; Zhao Y
    Mol Cancer; 2019 Dec; 18(1):173. PubMed ID: 31785619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.
    Martinez-Useros J; Garcia-Foncillas J
    Biomed Res Int; 2016; 2016():1869304. PubMed ID: 28078281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of glycoscience to the early detection of pancreatic cancer.
    Miyoshi E; Kamada Y
    Cancer Sci; 2016 Oct; 107(10):1357-1362. PubMed ID: 27418030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining and Treating Borderline Resectable Pancreatic Cancer.
    Perri G; Prakash L; Katz MHG
    Curr Treat Options Oncol; 2020 Jul; 21(9):71. PubMed ID: 32725270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress on circularRNAs in pancreatic cancer: emerging but promising.
    Wang YZ; An Y; Li BQ; Lu J; Guo JC
    Cancer Biol Ther; 2019; 20(9):1163-1171. PubMed ID: 31138014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for pancreatic cancer.
    Poruk KE; Firpo MA; Mulvihill SJ
    Adv Surg; 2014; 48():115-36. PubMed ID: 25293611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing the challenges of pancreatic cancer: future directions for improving outcomes.
    Hidalgo M; Cascinu S; Kleeff J; Labianca R; Löhr JM; Neoptolemos J; Real FX; Van Laethem JL; Heinemann V
    Pancreatology; 2015; 15(1):8-18. PubMed ID: 25547205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High risk factors of pancreatic carcinoma.
    Camara SN; Yin T; Yang M; Li X; Gong Q; Zhou J; Zhao G; Yang ZY; Aroun T; Kuete M; Ramdany S; Camara AK; Diallo AT; Feng Z; Ning X; Xiong JX; Tao J; Qin Q; Zhou W; Cui J; Huang M; Guo Y; Gou SM; Wang B; Liu T; Olivier OET; Conde T; Cisse M; Magassouba AS; Ballah S; Keita NLM; Souare IS; Toure A; Traore S; Balde AK; Keita N; Camara ND; Emmanuel D; Wu HS; Wang CY
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):295-304. PubMed ID: 27376795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer: diagnosis and treatments.
    Li HY; Cui ZM; Chen J; Guo XZ; Li YY
    Tumour Biol; 2015 Mar; 36(3):1375-84. PubMed ID: 25680410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for pancreatic cancer: why, how, and who?
    Poruk KE; Firpo MA; Adler DG; Mulvihill SJ
    Ann Surg; 2013 Jan; 257(1):17-26. PubMed ID: 22895395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patients.
    Wong T; Howes N; Threadgold J; Smart HL; Lombard MG; Gilmore I; Sutton R; Greenhalf W; Ellis I; Neoptolemos JP
    Pancreatology; 2001; 1(5):486-509. PubMed ID: 12120229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection markers in Pancreas Cancer.
    Farrell JJ; van Rijnsoever M; Elsaleh H
    Cancer Biomark; 2005; 1(2-3):157-75. PubMed ID: 17192037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
    Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
    World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical diagnostics of pancreatic cancer - Present and future.
    Jelski W; Mroczko B
    Clin Chim Acta; 2019 Nov; 498():47-51. PubMed ID: 31430440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Precancerous conditions and risk factors for pancreatic and bile duct cancer].
    Novotný I
    Klin Onkol; 2013; 26 Suppl():S29-33. PubMed ID: 24325160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular detection of pancreatic neoplasia: Current status and future promise.
    Majumder S; Chari ST; Ahlquist DA
    World J Gastroenterol; 2015 Oct; 21(40):11387-95. PubMed ID: 26526068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations in improving detection of pancreatic adenocarcinoma.
    Mendieta Zerón H; García Flores JR; Romero Prieto ML
    Future Oncol; 2009 Jun; 5(5):657-68. PubMed ID: 19519205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.